0.10Open0.10Pre Close0 Volume643 Open Interest60.00Strike Price0.00Turnover125.95%IV21.61%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.10Extrinsic Value100Contract SizeAmericanOptions Type-0.0257Delta0.0061Gamma764.10Leverage Ratio-0.0629Theta-0.0002Rho-19.61Eff Leverage0.0047Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet